Domov › Rakovina prsníka › Indiana
Klinické štúdie Rakovina prsníka v štáte Indiana
35 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v štáte Indiana.
Mestá v štáte Indiana
- Indianapolis20 štúdií
- Hammond9 štúdií
- Fort Wayne7 štúdií
- South Bend5 štúdií
- Evansville3 štúdií
- Richmond3 štúdií
- Gary3 štúdií
Oficiálny text štúdie (anglicky)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Investigative Clinical R of Indiana, Indianapolis
Prebieha náborFáza 3
Vek 18 až 100 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05827081A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
- Research Site, Fort Wayne
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07205822Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Reid Health, Richmond
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06625775Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
Prebieha náborFáza 2Vítaní zdravých dobrovoľníkov
Vek 18 až 45 · Ženy · Aktualizované 1. 10. 2026 · NCT05557877Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Community Health Network, Indianapolis
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06324357A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Fort Wayne Medical Oncology and Hematology ( Site 0084), Fort Wayne
- Franciscan Health ( Site 0077), Indianapolis
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06966700Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Northwest Cancer Center, Dyer
- Indiana University, Indianapolis
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Indiana University Health University Hospital, Indianapolis
- Deaconess GI Specialty Center, Newburgh
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 22. 9. 2026 · NCT07287098A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Indiana University (IU) School of Medicine, Indianapolis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213791A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Northwest Cancer Centers, PC, Dyer
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06492616Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Community Health Network, Inc, Indianapolis
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06982521Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
- IU Health Joe and Shelly Schwarz Cancer Center, Carmel
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT05846789Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Goshen Center for Cancer Care, Goshen
Prebieha náborObservačná štúdia
Vek 18 až 99 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07211178Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- IU Health West Hospital, Avon
- IU Health North Hospital, Carmel
- UChicago Medicine Northwest Indiana, Crown Point
- a 12 ďalších
Prebieha náborFáza 3
Vek 18 až 60 · Ženy · Aktualizované 2. 9. 2026 · NCT05879926Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Northwest Cancer Center, Dyer
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06072612HER2 Vaccine for Locally Advanced Breast Cancer
- Indiana University Melvin & Bren Simon Comprehensive Cancer Center, Indianapolis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT06949410HER-2 B Cell Peptide Vaccine
- Indiana University Melvin & Bren Simon Comprehensive Cancer Center, Indianpolis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT06414733E-Mindfulness Approaches for Living After Breast Cancer
- Goshen Center for Cancer Care, Goshen
- Baptist Health Floyd, New Albany
- Memorial Hospital of South Bend, South Bend
Prebieha náborFáza 3
Vek 18 až 50 · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT06748222Integrated Cancer Repository for Cancer Research
- Parkview Research Center, Fort Wayne
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699Exercise in Metastatic Breast Cancer: EMBody
- Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 4. 2026 · NCT05468034De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Northwest Cancer Center - Main Campus, Crown Point
- UChicago Medicine Northwest Indiana, Crown Point
- Northwest Oncology LLC, Dyer
- a 9 ďalších
Prebieha náborFáza 3
Vek 50 až 70 · Všetky pohlavia · Aktualizované 23. 4. 2026 · NCT04852887Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
- Indiana University, Indianapolis
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 4. 2026 · NCT04841148Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 4. 2026 · NCT05735080Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Woodland Cancer Care Center, Michigan City
- Reid Health, Richmond
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 3. 2026 · NCT06418204A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
- Research Site, Indianapolis
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 3. 2026 · NCT06956690NearWave Optical Molecular Monitoring
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
Prebieha nábor
Vek 18 a viac · Ženy · Aktualizované 17. 2. 2026 · NCT06744465EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- Deaconess Chancellor Center for Oncology, Newburgh
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT06401421cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Floyd, New Albany
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 a viac · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT05366881S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Franciscan Health Indianapolis, Indianapolis
- Franciscan Saint Elizabeth Health - Lafayette East, Lafayette
- Franciscan Health Mooresville, Mooresville
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 10. 2025 · NCT03418961First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
- Community Health Network, Indianapolis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2025 · NCT05216432MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- Parkview Health, Fort Wayne
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 8. 2025 · NCT03053193A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
- Northwest Cancer Center, Dyer
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 6. 2025 · NCT06568692BostonGene and Exigent Genomic INsight Study
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 2. 2025 · NCT06272864Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.